Cellgenic, a Subsidiary of Regenerative Medical Technology Group Inc., to Host Soft Opening of Advanced Cell Therapy Lab in Cancun

Reuters08-25

Cellgenic, a Subsidiary of <a href="https://laohu8.com/S/RMTG">Regenerative Medical Technology Group Inc.</a>, to Host Soft Opening of Advanced Cell Therapy Lab in Cancun

Regenerative Medical Technology Group Inc. (RMTG) has announced the soft opening of an advanced cell therapy manufacturing facility by its subsidiary Cellgenic in Cancun, Mexico. The opening, scheduled for September 2025, aligns with the ISSCA Regenerative Medicine Global Summit, attracting over 200 professionals from 30 countries. The facility, fully licensed by COFEPRIS, signifies a major step in RMTG's international expansion strategy, focusing on the manufacture, preservation, and distribution of human cellular products like mesenchymal stem cells and exosomes. The Cancun lab will enhance RMTG's decentralized production approach, aiming for efficient delivery and regulatory navigation, while also serving as a hub for research, clinical collaboration, and physician education through ISSCA training programs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerative Medical Technology Group Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1064625) on August 25, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2562424964?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-25 20:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2562424964","market":"us","top_or_hot":-1,"title":"Cellgenic, a Subsidiary of Regenerative Medical Technology Group Inc., to Host Soft Opening of Advanced Cell Therapy Lab in Cancun","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Cellgenic, a Subsidiary of <a href=\"https://laohu8.com/S/RMTG\">Regenerative Medical Technology Group Inc.</a>, to Host Soft Opening of Advanced Cell Therapy Lab in Cancun\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Regenerative Medical Technology Group Inc. (RMTG) has announced the soft opening of an advanced cell therapy manufacturing facility by its subsidiary Cellgenic in Cancun, Mexico. The opening, scheduled for September 2025, aligns with the ISSCA Regenerative Medicine Global <a href=\"https://laohu8.com/S/SMMT\">Summit</a>, attracting over 200 professionals from 30 countries. The facility, fully licensed by COFEPRIS, signifies a major step in RMTG's international expansion strategy, focusing on the manufacture, preservation, and distribution of human cellular products like mesenchymal stem cells and exosomes. The Cancun lab will enhance RMTG's decentralized production approach, aiming for efficient delivery and regulatory navigation, while also serving as a hub for research, clinical collaboration, and physician education through ISSCA training programs.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerative Medical Technology Group Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1064625) on August 25, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cellgenic, a Subsidiary of Regenerative Medical Technology Group Inc., to Host Soft Opening of Advanced Cell Therapy Lab in Cancun</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCellgenic, a Subsidiary of Regenerative Medical Technology Group Inc., to Host Soft Opening of Advanced Cell Therapy Lab in Cancun\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-25 20:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Cellgenic, a Subsidiary of <a href=\"https://laohu8.com/S/RMTG\">Regenerative Medical Technology Group Inc.</a>, to Host Soft Opening of Advanced Cell Therapy Lab in Cancun\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Regenerative Medical Technology Group Inc. (RMTG) has announced the soft opening of an advanced cell therapy manufacturing facility by its subsidiary Cellgenic in Cancun, Mexico. The opening, scheduled for September 2025, aligns with the ISSCA Regenerative Medicine Global <a href=\"https://laohu8.com/S/SMMT\">Summit</a>, attracting over 200 professionals from 30 countries. The facility, fully licensed by COFEPRIS, signifies a major step in RMTG's international expansion strategy, focusing on the manufacture, preservation, and distribution of human cellular products like mesenchymal stem cells and exosomes. The Cancun lab will enhance RMTG's decentralized production approach, aiming for efficient delivery and regulatory navigation, while also serving as a hub for research, clinical collaboration, and physician education through ISSCA training programs.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerative Medical Technology Group Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1064625) on August 25, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RMTG","symbol_name":"Regenerative Medical Technology Group Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nNDL6bfZxQ:1","article_id":"2562424964","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2562424964","pubTimestamp":1756123256,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Cellgenic, a Subsidiary of Regenerative Medical Technology Group Inc., to Host Soft Opening of Advanced Cell Therapy Lab in Cancun. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerative Medical Technology Group Inc. published the original content used to generate this news brief via ACCESS Newswire  on August 25, 2025, and is solely responsible for the information contained therein.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RMTG":"Regenerative Medical Technology Group Inc.","BK4200":"专卖店"},"translate_title":"再生医疗技术集团公司的子公司Cellgenic将在坎昆举办先进细胞治疗实验室的试营业","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RMTG":0.9},"content_text":"Cellgenic, a Subsidiary of Regenerative Medical Technology Group Inc., to Host Soft Opening of Advanced Cell Therapy Lab in Cancun\n    \n\n        Regenerative Medical Technology Group Inc. (RMTG) has announced the soft opening of an advanced cell therapy manufacturing facility by its subsidiary Cellgenic in Cancun, Mexico. The opening, scheduled for September 2025, aligns with the ISSCA Regenerative Medicine Global Summit, attracting over 200 professionals from 30 countries. The facility, fully licensed by COFEPRIS, signifies a major step in RMTG's international expansion strategy, focusing on the manufacture, preservation, and distribution of human cellular products like mesenchymal stem cells and exosomes. The Cancun lab will enhance RMTG's decentralized production approach, aiming for efficient delivery and regulatory navigation, while also serving as a hub for research, clinical collaboration, and physician education through ISSCA training programs.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerative Medical Technology Group Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1064625) on August 25, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2562424964","isCrawlerRequest":true}